Not all stocks in the index are doing well. If you're hunting for beaten-down bargains, these two laggards should top your ...

UnitedHealth's stock drop offers a rare value opportunity given recent acquisitions. UNH maintains industry-leading margins ...

Disappointing second-quarter results from Elevance Health might not bode well for UnitedHealth Group. UnitedHealth Group ...

Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by next year, the ...

Current parameters surrounding CVS Health represent a biased reward/risk ratio. Click here to see why I upgraded my rating of ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S.

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...

UnitedHealth Group (UNH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports ...

Dodge & Cox Fund, an investment management company, released its “Dodge and Cox Stock Fund” second quarter 2025 investor ...

Dealmaking increased employer plans' childbirth-related hospital bills 3.3% and physician services bills 15%. Hospital ...

UnitedHealth Group Inc. (NYSE: UNH) is one of the most oversold S&P 500 stocks so far in 2025. While the stock was down only marginally in 2024, it has declined substantially in 2025, placing it among ...